Following this, we next re-analyzed the CTHRC1 expression in different clinicopathological features of HNSC, KIRC, LIHC, LUAD, STAD, and UCEC, as a results, we also observed the significant (p < 0.05) up-regulation of CTHRC1 in different clinicopathological features of HNSC, KIRC, LIHC, LUAD, STAD, and UCEC including different cancer stages, patients races, genders, and age groups. Here, CTHRC1 is linked to cancer.